| 词条 | Botanix Pharmaceuticals |
| 释义 |
| name = Botanix Pharmaceuticals Limited | traded_as ={{ASX|BOT}} | logo = | type = Listed Public Company | foundation = 2002 | location = Perth, Australia | key_people = Dr. Roger New PhD (Research) Leon Ivory (non-executive director) | area_served = Global | industry = Biotechnology | products = | revenue = | operating_income = | net_income = | num_employees = | predecessor = | parent = | subsid = | homepage = http://www.botanixpharma.com | footnotes = }}Botanix Pharmaceuticals Limited, formerly Bone Medical, is a small Perth-based biopharmaceutical company aiming to develop medicines for bone and joint disease. Located in Technology Park Bentley, Perth, it focuses on orally administered preparations for treatment of osteoporosis and arthritis.[1][2] Since July 2007, its non-executive independent director has been Prof. Peter Brooks.[3] The company was named Bone Medical before July 2016, when after completing its acquisition of Botanix Pharmaceuticals Inc., a US-based medical dermatology company, it changed its name.[4][5] Research{{As of|2012|12}}, the company was utilising technologies under licence from Proxima Concepts Ltd of Jersey, Channel Islands,[6] in two clinical-trial projects aimed at improving administration of hormone replacement.[1]{{rp|p.2}}One explores use of oral calcitonin for treatment of bone disease including osteoporosis;[7] the other explores oral administration of parathyroid hormone, a controlling agent for the maintenance of normal calcium levels in the blood. Substitution of the latter for injected parathyroid hormone would potentially enhance accessibility and patient acceptance.[8] References1. ^1 ASX media release: Share Issue 2. ^{{cite web|url=http://www.ausbiotech.org/directory/details.asp?companyid={FCDD472B-E719-46D0-80F2-F8EA1853E6D1}&returntourl=%2Fdirectory%2Fsearch.asp%3Fpg%3D9 |title=Bone Medical Limited (BNE) |publisher=Ausbiotech.org |date= |accessdate=2012-08-13}} 3. ^[https://www.reuters.com/finance/stocks/officerProfile?symbol=BNE.AX&officerId=1014505 Brooks, Peter: Brief Biography] at Thomson Reuters 4. ^[https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=11750627 Company Overview of Bone Medical Ltd.] Bloomberg LP 5. ^[https://www.botanixpharma.com/wp-content/uploads/160321-BNE-Announces-Acquisition-of-Botanix-Media-Release.pdf Bone Medical Announces Acquisition of US-based Botanix Pharmaceuticals] 21 March 2016 6. ^Notice of change of interests of substantial holder at ASX, 2 December 2012 7. ^Capsitonin™ at official website 8. ^CaPTHymone™ at official website External links{{Portal|Business|Western_Australia|Medicine}}
4 : Biotechnology companies of Australia|Companies based in Perth, Western Australia|Biotechnology companies established in 2002|2002 establishments in Australia |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。